المؤلفون: Cunningham D; Royal Marsden Hospital, London, United Kingdom. david.cunningham@icr.ac.uk, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E

المصدر: The New England journal of medicine [N Engl J Med] 2004 Jul 22; Vol. 351 (4), pp. 337-45.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antibodies, Monoclonal/*administration & dosage , Antineoplastic Agents/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Camptothecin/*administration & dosage , Camptothecin/*analogs & derivatives , Colorectal Neoplasms/*drug therapy, Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/adverse effects ; Cetuximab ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Disease Progression ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Exanthema/chemically induced ; Female ; Humans ; Irinotecan ; Male ; Middle Aged ; Neoplasm Metastasis ; Single-Blind Method ; Survival Analysis ; Topoisomerase I Inhibitors